Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2+ Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab
Veronica Falcone(Medical University of Vienna), Georg Pfeiler(Medical University of Vienna), Myriam Stolz(Medical University of Vienna), Christian F. Singer(Comprehensive Cancer Center Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Christine Deutschmann(Universitätsklinik für Frauenheilkunde und Geburtshilfe), Lenka Grula(Medical University of Vienna), Elisabeth Reiser(Innsbruck Medical University), Anja Catic(Medical University of Vienna)
Cited by 2
Related Papers
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
|Annals of Oncology|2022|461
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422